Catalyst Wire Dossier Catalyst Wire Dossier

Cardonizumab

Cardonizumab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cardonizumab, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) [Phase 1]

See pricing